Driven by strong organic growth of 7.4% and the first-time consolidation of Tegra Medical, SFS Group increased its sales in the 2017 financial year by 13.7% to CHF 1,632.7 million. All segments contributed to this pleasing development. Changes in the scope of consolidation had a positive impact of 5.8% and currency movements added 0.5% to reported sales.
Please find detailed information in the media release published on 9 March 2018.
in CHF million
|Distribution & Logistics||160.2||162.7||322.9||312.8||3.2%|